Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.

Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34095605

about

eIF5A isoforms and cancer: two brothers for two functions?A novel mouse model for inhibition of DOHH-mediated hypusine modification reveals a crucial function in embryonic development, proliferation and oncogenic transformation The role of eIF5A in epidermal growth factor-induced proliferation of corneal epithelial cell association with PI3-k/Akt activation.Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation.Epithelial-mesenchymal transitions and hepatocarcinogenesis.Bidirectional regulation between WDR83 and its natural antisense transcript DHPS in gastric cancer.MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.Ablation of EIF5A2 induces tumor vasculature remodeling and improves tumor response to chemotherapy via regulation of matrix metalloproteinase 2 expression Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression Mitochondrial proteomics of nasopharyngeal carcinoma metastasis Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2.A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer A microarray-based gene expression analysis to identify diagnostic biomarkers for unknown primary cancer N1-guanyl-1,7-diaminoheptane sensitizes bladder cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2 activation.Overexpression of eukaryotic translation initiation factor 5A2 (EIF5A2) correlates with cell aggressiveness and poor survival in gastric cancer A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors.Biological Relevance and Therapeutic Potential of the Hypusine Modification System.MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma The translation factor eIF5A and human cancer.miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F Translational control in cancer etiology.Role of p38 and JNK MAPK signaling pathways and tumor suppressor p53 on induction of apoptosis in response to Ad-eIF5A1 in A549 lung cancer cells MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2.eIF5A2 is an alternative pathway for cell proliferation in cetuximab-treated epithelial hepatocellular carcinoma.Identification and validation of AIB1 and EIF5A2 for noninvasive detection of bladder cancer in urine samples EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo.MicroRNA-9 regulates non-small cell lung cancer cell invasion and migration by targeting eukaryotic translation initiation factor 5A2.The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.Biomarkers for predicting future metastasis of human gastrointestinal tumors.Roles of eukaryotic initiation factor 5A2 in human cancer.The proteome under translational control.Molecular functions and significance of the MTA family in hormone-independent cancer.The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma.Inhibition of AMPK-related kinase 5 (ARK5) enhances cisplatin cytotoxicity in non-small cell lung cancer cells through regulation of epithelial-mesenchymal transition Expression of eukaryotic translation initiation factor 5A-2 (eIF5A-2) associated with poor survival in gastric cancer.Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer.Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2.EIF5A2 is a novel chemoresistance gene in breast cancer.

P2860

Q26830163-E2611968-5F67-4FE1-88FC-B779B8523DE3 Q28510855-D51F4E9C-068E-442E-BDE6-3C53466749E2 Q30995793-50263042-DACD-42AE-8470-FF70551F458A Q31037974-31333BC5-25C3-463D-97E7-B5D8A68FD793 Q33755466-7759C30A-9CB6-47D2-AC61-121C4207B9A1 Q34267155-B75DDEFB-CAAB-4CA4-83B2-A572193571BD Q34333028-35D7E09C-43F5-4430-B127-E83F653A822B Q34334378-EBC07DC6-C331-4214-9DD0-88F11AFB67A9 Q34438689-33EBFC8F-1090-4981-819D-6BF0792CEA8D Q34502955-1C645502-C268-4A3E-A720-0445D439E3D5 Q34515582-40A0FC46-8FCE-4CA8-9AC0-FAC589236ABD Q34518559-31CD8636-FCAF-4A4B-96A1-96C64A11F044 Q34721103-4202EF0F-0AE9-4683-A753-893FF719CED4 Q35051469-6D62A467-1136-4311-832A-3B0DF58C18A6 Q35202594-A15CD20F-A40B-4CC7-BBD5-912931CF81C5 Q35716316-F54547AE-71E3-4B8B-B455-06E441A887C3 Q35883784-B6C9E414-0327-4D6D-A210-54E20B2A637F Q35970141-2B319177-9319-4F82-A248-13702FAD1AE4 Q36109579-2C882D74-E2F7-42D2-9142-4B7D087194EB Q36413366-55CC254E-930D-46C3-98A6-06DDDB1E006E Q36519353-CF6113B1-5761-4E05-9219-4F737D09159C Q36545884-328CF1D3-F038-4B76-B059-90EB7750FC85 Q36555212-CF12BCF9-19D3-4440-AD71-0EF531A07F8B Q36863596-D2A1877D-F61B-4776-9CA2-715A09676D8F Q37062650-F5C10859-99D7-40B7-B34C-FE16A5DAF54F Q37448092-46F3F7F4-F166-4967-AD49-07E3F45CAEC9 Q37520334-B705540A-A974-4103-BFA0-1F7F75F46860 Q37681730-7240789C-AB99-4662-9A78-C0BF7ADC288C Q37685242-6AE3B24E-73A7-4153-8BD3-F6146D019ECC Q37800217-B2E72EBB-C833-45CC-8886-43443560141C Q38078237-54DBFDE6-8531-4EE8-8EF5-3E71B362FC5C Q38163977-5011967F-D839-4510-9325-0904B1C8219E Q38255027-B3991BA1-E864-4BD5-B68B-02779049B79C Q38262308-ED7507C4-DB1D-4722-9788-2DACE05B67BF Q38781000-CB3E5BE9-5AA5-4CA7-8073-2583994F527B Q38806045-004D8BF9-F565-4099-86D6-5258E8B2C67E Q38843125-438A8FB3-5E46-4611-9727-F7FD04F64C29 Q38881007-31AF24A6-932D-48CF-9886-9DEBE5D82611 Q38996944-B37285D3-F299-4D0F-8CFE-D118BCB0FD1C Q39014521-DF6D08EF-8A59-4B6D-80EB-B23255AAAD77

P2860

Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34095605

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Overexpression of eukaryotic i ...... s in hepatocellular carcinoma.

@ast

Overexpression of eukaryotic i ...... s in hepatocellular carcinoma.

@en

Overexpression of eukaryotic i ...... s in hepatocellular carcinoma.

@nl

type

label

Overexpression of eukaryotic i ...... s in hepatocellular carcinoma.

@ast

Overexpression of eukaryotic i ...... s in hepatocellular carcinoma.

@en

Overexpression of eukaryotic i ...... s in hepatocellular carcinoma.

@nl

prefLabel

Overexpression of eukaryotic i ...... s in hepatocellular carcinoma.

@ast

Overexpression of eukaryotic i ...... s in hepatocellular carcinoma.

@en

Overexpression of eukaryotic i ...... s in hepatocellular carcinoma.

@nl

P1433

Q34095605-FEE486F8-5CA2-42FF-BDE1-C9D54AC9731E

P1476

Q34095605-D5BD65FA-C864-4F67-B4DC-AE68677C9EE1

P2093

Q34095605-0D196B07-BBC6-4099-B000-333453B8BDB8

Q34095605-6D531D40-644F-4A22-A25F-E5D5CD214F4F

Q34095605-91504099-15FA-4437-962A-75A3ED3E8B5E

Q34095605-920AFD3D-F44C-4474-AD34-DBF0ABDA862A

Q34095605-A5AE8712-C017-4234-9B65-D7C25E8012F7

Q34095605-A717A27A-31C8-468B-9344-9DE41A58041F

Q34095605-EE2ECFFE-5309-4F33-B775-EB5347E80B27

P2860

Q34095605-001E1D94-281B-4876-8297-8C3A0D98A448

Q34095605-0077EAC2-A9C5-4F09-8229-1FD0C20C6129

Q34095605-197A979F-85A3-42EE-8DE9-A779C98E2B16

Q34095605-1D6530C5-4B46-4A04-88D8-74382E48FDD9

Q34095605-2DEEA971-1EE5-42C2-BD8F-0DBAD196428C

Q34095605-5221BD65-3B86-471A-8344-A605C74AA48E

Q34095605-566CE0C6-FB8C-48F6-B4E6-BA017A6CFC1B

Q34095605-56F52EA1-0C54-4E72-813E-37862ACB0E94

Q34095605-764316B5-1C07-4CBF-A07A-85B750E092C1

Q34095605-771D6807-6D77-4CA0-A115-220B20E8FFDE

P304

Q34095605-22584135-C485-4645-83FD-9C33CF7E0077

P31

Q34095605-D2995187-74E6-4403-A095-3940B7C7F63E

P356

Q34095605-831437C8-7EC8-4A2C-B065-2929750AC4A1

P407

Q34095605-78D4ECA5-9D47-44B4-B26E-21F3763C2291

P433

Q34095605-B5FCBEFA-87EC-471E-B4AA-73A680819400

P478

Q34095605-218E76F0-4E6E-4CE9-9DFD-5C6604F671B2

P50

Q34095605-9E90E034-7FAE-4C5D-918E-920CCA5673CF

Q34095605-E4A73E61-DB40-42D4-A97C-4734F87CA608

Q34095605-E9F94294-E6B2-4A0A-BAEB-5B9ADEA5DE7D

P577

Q34095605-F8A4E7D6-C54A-4439-A408-FB025D5FBFAC

P5875

Q34095605-F4F5F954-D9CA-43D7-A043-EE38EF2A2241

P698

Q34095605-705E094E-41F7-4872-9C9F-A51B3D345A8E

P921

Q34095605-9356AB37-DCC5-4054-855E-2B2B107BF41A

P356

P1433

P1476

Overexpression of eukaryotic i ...... is in hepatocellular carcinoma

@en

P2093

Dan Xie

http://www.w3.org/2001/XMLSchema#string

Dong-Jiang Tang

http://www.w3.org/2001/XMLSchema#string

Ning-Fang Ma

http://www.w3.org/2001/XMLSchema#string

Sui-Sui Dong

http://www.w3.org/2001/XMLSchema#string

Sze Hang Lau

http://www.w3.org/2001/XMLSchema#string

Yan Li

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of eukaryotic initiation factor 5A-2

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Global cancer statistics, 2002

A molecular signature of metastasis in primary solid tumors

Epithelial-mesenchymal transitions in development and pathologies

Cell migration: Rho GTPases lead the way

The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology.

Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion.

Oncogenic role of eIF-5A2 in the development of ovarian cancer.

Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma.

P304

1255-1263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.23451

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41175683

http://www.w3.org/2001/XMLSchema#string

P698

20112425

http://www.w3.org/2001/XMLSchema#string

P921